HBX

Hana Biosciences (HBX)

Hana Biosciences

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:HBX

日付	受信時刻	ニュースソース	見出し	コード	企業名
2006/04/11	20 : 03	Business Wire	Hana Biosciences Obtains NASDAQ National Market Listing Approval; Hana Biosciences Shares to Trade Under Symbol HNAB on the NAS	AMEX:HBX	Hana Biosciences
2006/04/05	20 : 03	Business Wire	Hana Biosciences to Present at the BIO 2006 Business Forum	AMEX:HBX	Hana Biosciences
2006/04/01	00 : 03	Business Wire	Hana Biosciences to Present at the CIBC World Markets Annual Biotechnology & Specialty Pharmaceutical Conference	AMEX:HBX	Hana Biosciences
2006/03/31	21 : 03	Business Wire	Hana Biosciences Initiates Talotrexin Phase II Clinical Trials in Relapsed or Refractory Non-Small Cell Lung Cancer (NSCLC)	AMEX:HBX	Hana Biosciences
2006/03/23	07 : 23	Business Wire	Hana Biosciences to Present at the Bear Stearns' Bear Biotech West Coast Confab	AMEX:HBX	Hana Biosciences
2006/03/16	18 : 03	Business Wire	Hana Biosciences Reports 2005 Results from Operations	AMEX:HBX	Hana Biosciences
2006/03/09	21 : 02	Business Wire	Hana Biosciences Successfully Completes Pivotal Trials of Zensana(TM), First Proprietary Ondansetron Oral Spray for Chemotherap	AMEX:HBX	Hana Biosciences
2006/03/06	22 : 30	Business Wire	Hana Biosciences to Present at the Lehman Brothers 9th Annual Global Healthcare Conference	AMEX:HBX	Hana Biosciences
2006/03/02	22 : 30	Business Wire	Hana Biosciences to Present at BioSquare 2006	AMEX:HBX	Hana Biosciences
2006/02/28	22 : 30	Business Wire	Hana Biosciences to Present at the Cowen & Co. 26th Annual Health Care Conference	AMEX:HBX	Hana Biosciences
2006/02/14	22 : 30	Business Wire	Hana Biosciences Announces Issuance of Talotrexin Patent	AMEX:HBX	Hana Biosciences
2006/02/07	22 : 27	Business Wire	Hana Biosciences to Present at the 8th Annual BIO CEO & Investor Conference	AMEX:HBX	Hana Biosciences
2006/01/09	22 : 14	Business Wire	Hana Biosciences Announces Positive Results of Initial Registration Trial with Zensana(TM), First Ondansetron Oral Spray for Che	AMEX:HBX	Hana Biosciences
2006/01/05	20 : 00	Business Wire	Hana Biosciences Announces 2006 Corporate Goals; Key 2005 Achievements Reviewed and 2006 Objectives Announced; Annual Shareholde	AMEX:HBX	Hana Biosciences
2005/11/18	02 : 07	Business Wire	Hana Biosciences Announces Positive In Vivo Preclinical Results Confirming Pharmacokinetics of Zensana(TM) (Ondansetron Oral Spr	AMEX:HBX	Hana Biosciences
2005/11/14	21 : 58	Business Wire	Hana Biosciences Announces Positive Interim Results From a Phase I Trial of Talotrexin (PT-523) in Relapsed or Refractory Non-Sm	AMEX:HBX	Hana Biosciences
2005/11/07	22 : 24	Business Wire	Hana Biosciences to Present at the Rodman & Renshaw Techvest 7th Annual Healthcare Conference	AMEX:HBX	Hana Biosciences
2005/10/26	21 : 28	Business Wire	Hana Biosciences to Present at 3rd Annual PIPES Conference	AMEX:HBX	Hana Biosciences
2005/10/25	21 : 30	Business Wire	Hana Biosciences Completes Previously Announced Private Placement	AMEX:HBX	Hana Biosciences
2005/10/24	20 : 58	Business Wire	Hana Biosciences to Present at Life Sciences Conference Hosted by C.E. Unterberg, Towbin	AMEX:HBX	Hana Biosciences
2005/10/20	04 : 41	Business Wire	Hana Biosciences Announces $14.7 Million Private Placement	AMEX:HBX	Hana Biosciences
2005/10/03	22 : 46	Business Wire	Hana Biosciences to Present at BioContact Quebec 2005	AMEX:HBX	Hana Biosciences
2005/09/23	02 : 45	PR Newswire (US)	American Stock Exchange Lists Common Stock of Hana Biosciences Incorporated	AMEX:HBX